| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-14 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-13 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-12 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-11 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.24 | 3e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-11 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-11 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-11 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |